. home.aspx



Migraine patient or doctor? Demand more, Biohaven advises in new awareness push

July 16, 2019 / Beth Snyder Bulik

Biohaven is urging patients and physicians to Demand More from acute migraine treatments. Thats the tagline of its just-launched effort to draw attention to the lack of satisfactory options. Biohaven debuted the work at the recent American Headache Society annual meeting. At the center of the campaign and website are patients holding signs that spell out their frustrations with current acute migraine treatments. Those include, I need an acute treatment that can work the first time and, Migraine treatments should impact my symptoms. Not my life. Migraine patients often treat headaches with non-steroidal anti-inflammatory drugs (NSAIDs), triptans, or even more powerful narcotics, but Biohaven’s research found that many people are not satisfied with those drugs' side effects and with having to take multiple medicines or dose frequently, Biohaven CEO Vlad Coric said. The campaign is intentionally bold, and in fact, Biohaven rejected the first round of ad submissions. Coric said t...